# Nanoly Bioscience, Inc. — Form D

Nanoly Bioscience, Inc. of DENVER, CO, a company, filed a Form D exempt-offering notice with the SEC on 2016-05-11. The offering totals $1.5M, of which $1.1M was reported sold. Industry: Other.

## Offering

- Filed: 2016-05-11
- Form: D
- Accession: 0001673739-16-000002
- Industry: Other
- Exemptions: 06b
- Total offering: $1.5M
- Amount sold: $1.1M
- Remaining: $415K
- Investors: 3
- Date of first sale: 2016-05-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-262910

## Issuer

- Name: Nanoly Bioscience, Inc.
- CIK: 0001673739
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 9066 E. COLORADO CIRCLE, DENVER, CO, 80231
- Phone: (720) 273-2875

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Nanxi Liu | Director | Santa Monica, CA |
| Balaji Sridhar | Director | Denver, CO |
| Carole Bellis | Executive Officer | Denver, CO |
| Nanxi Liu | Executive Officer | Santa Monica, CA |
| Balaji Sridhar | Executive Officer | Denver, CO |

## More

- [CIK 1673739 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1673739&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001673739-16-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.